CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,000 | -93.5% | 1,267 | -91.7% | 0.00% | -100.0% |
Q1 2022 | $31,000 | -51.6% | 15,203 | -35.6% | 0.00% | -50.0% |
Q4 2021 | $64,000 | -26.4% | 23,623 | +58.5% | 0.00% | -77.8% |
Q3 2020 | $87,000 | +2800.0% | 14,907 | +3812.6% | 0.01% | – |
Q2 2020 | $3,000 | -62.5% | 381 | -70.2% | 0.00% | -100.0% |
Q1 2020 | $8,000 | -83.0% | 1,279 | -89.4% | 0.00% | -71.4% |
Q3 2019 | $47,000 | +30.6% | 12,029 | +725.6% | 0.01% | 0.0% |
Q1 2019 | $36,000 | +3500.0% | 1,457 | +5103.6% | 0.01% | – |
Q4 2018 | $1,000 | -98.7% | 28 | -98.9% | 0.00% | -100.0% |
Q3 2018 | $76,000 | +1166.7% | 2,596 | +2118.8% | 0.03% | +766.7% |
Q1 2018 | $6,000 | -75.0% | 117 | -67.4% | 0.00% | -83.3% |
Q4 2017 | $24,000 | +2300.0% | 359 | +5028.6% | 0.02% | +1700.0% |
Q2 2017 | $1,000 | – | 7 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |